PORTLAND, Ore., Oct. 13, 2008 (GLOBE NEWSWIRE) -- Znomics, Inc. (OTCBB:ZNOM), a company seeking to discover new drugs using an improved discovery process combining advanced zebrafish technologies and medicinal chemistry, today announced that it has reached a significant research development milestone resulting in the company seeking patent protection for its proprietary zebrafish technologies.
